ArticleAnnals of clinical and translational neurology2025

Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis.

Alexandra Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.